Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • CLX vs GSK✓SelectedUSD · GSKCLX vs GSK performance historyLatest closeAs of+1.58%11/18
Stock and ETF performance explorer

CLX vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-21.5%
GSK return
+42.7%
Excess return
-64.2%
Maximum drawdown
-49.1%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+1.6%-1.3%+2.9%+1.9%
7D+1.4%-3.1%+4.6%+2.1%
30D+28.5%-0.9%+29.4%+28.8%
3M+4.2%-4.2%+8.4%+5.1%
6M+19.9%-1.6%+21.4%+20.2%
YTD+13.0%+2.6%+10.4%+12.6%
1Y+13.7%+6.2%+7.5%+12.7%
3Y-12.2%+55.0%-67.2%-19.2%
5Y-21.5%+42.8%-64.3%-25.5%
All-21.5%+42.7%-64.2%-25.5%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling